Robert-Piessard, S.

P52

J. Enz. Inh. Med. Chem. 2006, 21, 277-283.

3-(a-Azolylbenzyl)indoles: in vitro and in vivo anti-Leishmania activity and mechanism of action.

P41

J. Enz. Inh. Med. Chem. 2004, 19, 459-465.

Synthesis and evaluation of N3-imidazolidin-2-one acting as potential immunosuppressive agents.

Sabourin, C. | Robert, J-M.H. | Robert-Piessard, S. | Carbonnelle, D. | Lang, F.

P33

Eur. J. Med. Chem. 2003, 38, 711-718.

Synthesis and antileismanial activity of new imidazolidin-2-one derivatives.

P21

J. Enz. Inh. Med. Chem. 2002, 17, 425-429.

In vitro activity of new antifungal 3-(a-azolylbenzyl)indoles against Aspergillus fumigatus.

P7

Arzneim.-Forsch./Drug Res. 2000, 50 (I), 479-484.

Synthesis and antileishmanial activity of new 1-(pyridin-2-yl)imidazolidin-2-ones derived from 2-amino-4,6-dimethylpyridine.

P4

J. Pharm. Pharmacol. 1999, 51 (S), 113.

New 7-(a-azolylbenzyl)-indoles and indolines acting as P450 aromatase inhibitors.